Knowledge of and interest in hepatitis C treatment at a methadone clinic

Journal of Substance Abuse Treatment

Volumn 28, Issue 2, 2005, Pages 181-187

  Walley, Alexander Y ^a   White, Mary C ^b   Kushel, Margot B ^b   Song, Yong S ^b   Tulsky, Jacqueline P ^b  

^a Dimock Community Health Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis C; Injection drug users; Interest in treatment; Knowledge of treatment; Methadone

Indexed keywords

METHADONE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; HEALTH BEHAVIOR; HEPATITIS C; HEPATITIS C VIRUS; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT EDUCATION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK BENEFIT ANALYSIS; SEX DIFFERENCE;

EID: 15044362714     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2004.12.004     Document Type: Article

References (26)

1. J. Astone, S.M. Strauss, Z.P. Vassilev, and D.C. Des Jarlais Provision of hepatitis C education in a nationwide sample of drug treatment programs Journal of Drug Education 33 2003 107 117
2. M. Backmund, K. Meyer, M. Von Zielonka, and D. Eichenlaub Treatment of hepatitis C infection in injection drug users Hepatology 34 2001 188 193
3. D. Best, A. Noble, E. Finch, M. Gossop, C. Sidwell, and J. Strang Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment British Medical Journal 319 1999 290 291
4. Centers for Disease Control and Prevention Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease Morbidity and Mortality Weekly Report 47 1998 1 39
5. G.L. Davis, and J.R. Rodrigue Treatment of chronic hepatitis C in active drug users New England Journal of Medicine 345 2001 215 217
6. V.P. Dhopesh, K.R. Taylor, and W.M. Burke Survey of hepatitis B and C in addiction treatment unit American Journal of Drug and Alcohol Abuse 26 2000 703 707
7. B.R. Edlin, K.H. Seal, J. Lorvick, A.H. Kral, D.H. Ciccarone, L.D. Moore, and B. Lo Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? New England Journal of Medicine 345 2001 211 215
8. P.D. Friedmann, J.A. Alexander, and T.A. D'Aunno Organizational correlates of access to primary care and mental health services in drug abuse treatment units Journal of Substance Abuse Treatment 16 1999 71 80
9. S.B. Ho, H. Nguyen, L.L. Tetrick, G.A. Opitz, M.L. Basara, and E. Dieperink Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population American Journal of Gastroenterology 96 2001 157 164
10. M.E. Johnson, D.G. Fisher, A. Fenaughty, and S.A. Theno Hepatitis C virus and depression in drug users American Journal of Gastroenterology 93 1998 785 789
11. C.S. Murrill, H. Weeks, B.C. Castrucci, H.S. Weinstock, B.P. Bell, C. Spruill, and M. Gwinn Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in six US cities American Journal of Public Health 92 2002 385 387
12. National Institutes of Health. (2002). National Institutes of Health consensus development conference statement on the management of hepatitis C: 2002. Available: consensus.nih.gov/cons/116/116cdc_intro.htm.
13. National Institutes of Health. (1997). National Institutes of Health consensus development conference statement on the management of hepatitis C. Available: consensus.nih.gov/cons/105/105_intro.htm.
14. D.M. Novick The impact of hepatitis C virus infection on methadone maintenance treatment Mount Sinai Journal of Medicine 67 2000 437 443
15. P. Piccolo, L. Borg, A. Lin, D. Melia, A. Ho, and M.J. Kreek Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment Journal of Addictive Diseases 21 2002 55 66
16. C.C. Pratt, D. Paone, R.J. Carter, and M.C. Layton Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City American Journal of Public Health 92 2002 1254 1256
17. J.H. Samet, P. Friedmann, and R. Saitz Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives Archives of Internal Medicine 161 2001 85 91
18. J.L. Sorensen, and A.L. Copeland Drug abuse treatment as an HIV prevention strategy: a review Drug and Alcohol Dependence 59 2000 17 31
19. J.L. Sorensen, C.L. Masson, and D.C. Perlman HIV/hepatitis prevention in drug abuse treatment programs: Guidance for Research Science and Practice Perspectives 1 2002 4 11
20. B.D. Smedley A.Y. Stith A.R. Nelson Unequal Treatment: Confronting Ethnic and Racial Disparities in Healthcare 2002 The National Academies Press Washington, DC
21. M.D. Stein, J. Maksad, and J. Clarke Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment Drug and Alcohol Dependence 61 2001 211 215
22. S.M. Strauss, J. Astone, Z.P. Vassilev, D.C. Des Jarlais, and H. Hagan Gaps in the drug-free and methadone treatment program response to Hepatitis C Journal of Substance Abuse Treatment 24 2003 291 297
23. S.M. Strauss, G.P. Falkin, Z. Vassilev, D.C. Des Jarlais, and J. Astone A nationwide survey of hepatitis C services provided by drug treatment programs Journal of Substance Abuse Treatment 22 2002 55 62
24. D.L. Sylvestre Treating hepatitis C in methadone maintenance patients: an interim analysis Drug and Alcohol Dependence 67 2002 117 123
25. A. Umbricht-Schneiter, D.H. Ginn, K.M. Pabst, and G.E. Bigelow Providing medical care to methadone clinic patients: referral vs. on-site care American Journal Public Health 84 1994 207 210
26. S. Zierler, and N. Krieger Reframing women's risk: Social inequalities and HIV infection Annual Review of Public Health 18 1997 401 436